EN | DE TOP BAR MENU Investors & Media Careers Connect Healthcare Professionals Our DNA How We Translate Science For Patients COVID-19 OUR VISION Harnessing the power of the immune system to develop novel therapies against cancer and infectious diseases LEARN MORE Cookies are used by us and third parties on our site. For all cookies that are not technically necessary, we require your consent (e.g. cookies for statistical purposes, tracking, analytics, advertising, if necessary configuration). By selecting or deselecting the cookies, you consent to or reject the processing of your personal data (e.g. your IP address) for the respective purpose. You can revoke or give your consent at any time in our Data Privacy Policy under the item "Cookies". Essential Statistics Marketing Performance External Media Personalisation Save preferences ACCEPT ALL COOKIES Hello! I am Edward, your virtual contact partner from BioNTech. Feel free to ask me your questions.

Skip to main navigation Topbar Nav Investors & Media Careers Connect MAIN NAVIGATION Main navigation Our DNA How We Translate Science For Patients COVID-19 Media Materials IR Side Nav Overview Press Releases Events & Presentations Publications SEC Filings Financial Reports Financial Calendar Corporate Governance Analyst Coverage Stock Information Shareholder Fraud Warning Shareholder Information Investor FAQ Media Materials Sign-up for Email Alerts Investor Contact Sylke Maas, Ph.D. VP Investor Relations & Strategy Send Email +49 6131 9084-0 For U.S. Investors: Westwicke John Woolford Send Email +1 443 213-0506 Media Contact Jasmina Alatovic Director Global External Communications Send Email +49 6131 9084-0 GERMAN Media Materials In this section you can find a variety of media materials and useful information to download. Show All iNeST COVID-19 vaccine candidate BNT162 Logo Management Laboratory & scientific images Marburg Manufacturing Site Facilities Fact Sheets BioNTech SE holds all copy and distribution rights to the pictures on this website. Usage of images requires written approval by BioNTech SE and indication of the source as “© BioNTech SE 2021, all rights reserved”. Please inform us about the use of images from our library before publication via email to media@biontech.de Images may not be modified or combined with other images in any way. A permanent storage on electronic systems is not permitted. Before footer menu Information Request RSS Feeds BioNTech SE An der Goldgrube 12 55131 Mainz Germany T: +49 6131 9084-0 For questions on logistics, handling or other issues: service@biontech.de For any other questions, please use our contact form at connect.biontech.de We aspire to utilize the full potential of the immune system to fight cancer and infectious diseases 02. Footer Column2 Links Connect Our DNA How We Translate Science For Patients Investors & Media Careers 03. Footer Column3 Links Imprint Terms Of Use General Terms And Conditions General Conditions Of Purchase Data Privacy Statement Data Processing Terms Business Partners Adverse Event Reporting Cookie Settings Follow us © Copyright BioNTech SE 2021. All Rights Reserved.